A first interesting observation about these genes is that many of them have been positively implicated in breast and/or lung cancer progression and resistance to therapy: AURKA[33], [34], CAV2[35], RAB27A[36], RAD51[37]–[39], TIMELESS[40], TIMM17A[41]. Here, CAV2 is linked to lung carcinoma.